Deep clinical and neuropathological phenotyping of Pick disease

Annals of Neurology

Volumn 79, Issue 2, 2016, Pages 272-287

  Irwin, David J ^a,b   Brettschneider, Johannes ^c   McMillan, Corey T ^a   Cooper, Felicia ^a,b   Olm, Christopher ^a   Arnold, Steven E ^b   Van Deerlin, Vivianna M ^b   Seeley, William W ^e   Miller, Bruce L ^e   Lee, Edward B ^b,d   Lee, Virginia M Y ^b   Grossman, Murray ^a   Trojanowski, John Q ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Hospital Herford   (Germany)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; TAU PROTEIN; UBIQUITIN; MAPT PROTEIN, HUMAN; THIAZOLE DERIVATIVE; THIOFLAVINE;

ADULT; AGED; AMYGDALOID NUCLEUS; ANGULAR GYRUS; ANTERIOR CINGULATE; ARTICLE; AUDITORY HALLUCINATION; BASAL GANGLION; BRAIN WEIGHT; CAUDATE NUCLEUS; CEREBRAL CRUS; CLINICAL FEATURE; CONTROLLED STUDY; DENTATE GYRUS; DISEASE COURSE; DISEASE DURATION; ENTORHINAL CORTEX; EPISODIC MEMORY; FEMALE; FOLLOW UP; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; GLOBUS PALLIDUS; GRAY MATTER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFERIOR OLIVE; LIMBIC CORTEX; LOCUS CERULEUS; MALE; MEDULLARY PYRAMID; MESENCEPHALON; MIDDLE AGED; MIDDLE FRONTAL GYRUS; NEOCORTEX; NEUROIMAGING; NEUROPATHOLOGY; NEUROPIL THREAD; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; ORBITAL CORTEX; PHENOTYPE; PICK PRESENILE DEMENTIA; PONS; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; PROTEIN ACETYLATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PUTAMEN; RAPHE NUCLEUS; RED NUCLEUS; RETICULAR FORMATION; STRIATE CORTEX; SUBSTANTIA NIGRA; SUPERIOR TEMPORAL GYRUS; VERY ELDERLY; VISUAL CORTEX; WHITE MATTER; WORKING MEMORY; BRAIN CORTEX; LIMBIC SYSTEM; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; STAINING;

AGED; AGED, 80 AND OVER; CEREBRAL CORTEX; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIMBIC SYSTEM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PHENOTYPE; PICK DISEASE OF THE BRAIN; STAINING AND LABELING; TAU PROTEINS; THIAZOLES;

EID: 84958112565     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24559     Document Type: Article

References (50)

1. Pick A,. Über die Beziehungen der senilen Hirnatrophie zur Aphasie. Prag Med Wochenschr 1892; 17: 165-167.
2. Kertesz A,. Pick complex-historical introduction. Alzheimer Dis Assoc Disord 2007; 21: S5-S7.
3. Mackenzie IR, Neumann M, Bigio EH, et al., Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol 2010; 119: 1-4.
4. Yokota O, Tsuchiya K, Arai T, et al., Clinicopathological characterization of Pick's disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions. Acta Neuropathol 2009; 117: 429-444.
5. Piguet O, Halliday GM, Reid WG, et al., Clinical phenotypes in autopsy-confirmed Pick disease. Neurology 2011; 76: 253-259.
6. Rascovsky K, Hodges JR, Knopman D, et al., Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011; 134 (pt 9): 2456-2477.
7. Gorno-Tempini ML, Hillis AE, Weintraub S, et al., Classification of primary progressive aphasia and its variants. Neurology 2011; 76: 1006-1014.
8. Dickson D, ed. Sporadic tauopaties: Pick's disease, corticobasal degeneration, progressive supranuclear palsy and argyrophilic grain disease. 2nd ed. New York, NY: Cambridge University Press, 2004.
9. Toledo JB, Van Deerlin VM, Lee EB, et al., A platform for discovery: the University of Pennsylvania Integrated Neurodegenerative Disease Biobank. Alzheimers Dement 2014; 10: 477-484.
10. Montine TJ, Phelps CH, Beach TG, et al., National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol 2012; 123: 1-11.
11. Van Deerlin VM, Forman MS, Farmer JM, et al., Biochemical and pathological characterization of frontotemporal dementia due to a Leu266Val mutation in microtubule-associated protein tau in an African American individual. Acta Neuropathol 2007; 113: 471-479.
12. Hogg M, Grujic ZM, Baker M, et al., The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy. Acta Neuropathol 2003; 106: 323-336.
13. Feldengut S, Del Tredici K, Braak H,. Paraffin sections of 70-100 μm: a novel technique and its benefits for studying the nervous system. J Neurosci Methods 2013; 215: 241-244.
14. Mercken M, Vandermeeren M, Lubke U, et al., Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol 1992; 84: 265-272.
15. Brettschneider J, Del Tredici K, Irwin DJ, et al., Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD). Acta Neuropathol 2014; 127: 423-439.
16. Seubert P, Mawal-Dewan M, Barbour R, et al., Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau. J Biol Chem 1995; 270: 18917-18922.
17. Hasegawa M, Fujiwara H, Nonaka T, et al., Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions. J Biol Chem 2002; 277: 49071-49076.
18. de Silva R, Lashley T, Gibb G, et al., Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathol Appl Neurobiol 2003; 29: 288-302.
19. Dan A, Takahashi M, Masuda-Suzukake M, et al., Extensive deamidation at asparagine residue 279 accounts for weak immunoreactivity of tau with RD4 antibody in Alzheimer's disease brain. Acta Neuropathol Commun 2013; 1: 54.
20. Guillozet-Bongaarts AL, Garcia-Sierra F, Reynolds MR, et al., Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease. Neurobiol Aging 2005; 26: 1015-1022.
21. Irwin DJ, Cohen TJ, Grossman M, et al., Acetylated tau neuropathology in sporadic and hereditary tauopathies. Am J Pathol 2013; 183: 344-351.
22. Irwin DJ, Cohen TJ, Grossman M, et al., Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies. Brain 2012; 135 (pt 3): 807-818.
23. Igaz LM, Kwong LK, Lee EB, et al., Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice. J Clin Invest 2011; 121: 726-738.
24. Volpicelli-Daley LA, Luk KC, Patel TP, et al., Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 2011; 72: 57-71.
25. Montine TJ, Monsell SE, Beach TG, et al., Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease. Alzheimers Dement (in press).
26. Uchihara T, Tsuchiya K,. Neuropathology of Pick body disease. Handb Clin Neurol 2008; 89: 415-430.
27. McMillan C, Irwin D, Avants B, et al., White matter imaging helps dissociate tau from TDP-43 in frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry 2013; 84: 949-955.
28. Mori S, Oishi K, Jiang H, et al., Stereotaxic white matter atlas based on diffusion tensor imaging in an ICBM template. Neuroimage 2008; 40: 570-582.
29. Feany MB, Mattiace LA, Dickson DW,. Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration. J Neuropathol Exp Neurol 1996; 55: 53-67.
30. Zhukareva V, Mann D, Pickering-Brown S, et al., Sporadic Pick's disease: a tauopathy characterized by a spectrum of pathological tau isoforms in gray and white matter. Ann Neurol 2002; 51: 730-739.
31. Probst A, Tolnay M, Langui D, et al., Pick's disease: hyperphosphorylated tau protein segregates to the somatoaxonal compartment. Acta Neuropathol 1996; 92: 588-596.
32. Armstrong MJ, Litvan I, Lang AE, et al., Criteria for the diagnosis of corticobasal degeneration. Neurology 2013; 80: 496-503.
33. Berry RW, Sweet AP, Clark FA, et al., Tau epitope display in progressive supranuclear palsy and corticobasal degeneration. J Neurocytol 2004; 33: 287-295.
34. Guillozet-Bongaarts AL, Glajch KE, Libson EG, et al., Phosphorylation and cleavage of tau in non-AD tauopathies. Acta Neuropathol 2007; 113: 513-520.
35. Schmidt ML, Schuck T, Sheridan S, et al., The fluorescent Congo red derivative, (trans, trans)-1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene (BSB), labels diverse beta-pleated sheet structures in postmortem human neurodegenerative disease brains. Am J Pathol 2001; 159: 937-943.
36. Miki Y, Mori F, Tanji K, et al., An autopsy case of incipient Pick's disease: immunohistochemical profile of early-stage Pick body formation. Neuropathology 2014; 34: 386-391.
37. Hornberger M, Piguet O,. Episodic memory in frontotemporal dementia: a critical review. Brain 2012; 135 (pt 3): 678-692.
38. Towfighi J,. Early Pick's disease. A light and ultrastructural study. Acta Neuropathol 1972; 21: 224-231.
39. Sparks DL, Danner FW, Davis DG, et al., Neurochemical and histopathologic alterations characteristic of Pick's disease in a non-demented individual. Journal of neuropathology and experimental neurology 1994; 53: 37-42.
40. Mimuro M, Yoshida M, Miyao S, Harada T, Ishiguro K, Hashizume Y,. Neuronal and glial tau pathology in early frontotemporal lobar degeneration-tau, Pick's disease subtype. J Neurol Sci 2010; 290: 177-182.
41. Seeley WW, Crawford R, Rascovsky K, et al., Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia. Arch Neurol 2008; 65: 249-255.
42. Kim EJ, Sidhu M, Gaus SE, et al., Selective frontoinsular von Economo neuron and fork cell loss in early behavioral variant frontotemporal dementia. Cereb Cortex 2012; 22: 251-259.
43. Seeley WW, Carlin DA, Allman JM, et al., Early frontotemporal dementia targets neurons unique to apes and humans. Ann Neurol 2006; 60: 660-667.
44. Arai T, Ikeda K, Akiyama H, et al., Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol 2001; 101: 167-173.
45. Kersaitis C, Halliday GM, Kril JJ,. Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies. Acta Neuropathol 2004; 108: 515-523.
46. Whitwell JL, Josephs KA, Rossor MN, et al., Magnetic resonance imaging signatures of tissue pathology in frontotemporal dementia. Arch Neurol 2005; 62: 1402-1408.
47. Braak H, Braak E,. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-259.
48. Brettschneider J, Del Tredici K, Toledo JB, et al., Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol 2013; 74: 20-38.
49. Kovacs GG, Rozemuller AJ, van Swieten JC, et al., Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium. Neuropathol Appl Neurobiol 2013; 39: 166-178.
50. Maruyama M, Shimada H, Suhara T, et al., Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron 2013; 79: 1094-1108.